NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approximately 66% Reduction in Net Loss
PR Newswire•12/11/2026•08:01 ET
0
Key Highlights
- ➤Gross profit $3.678M, up nearly 35% year-over-year
- ➤Consolidated gross margin 35.0%, versus 19.9% in 2025
- ➤Pharmacy contract revenue $2.4M, up 300% year-over-year
- ➤Net loss $0.748M, down approximately 66% year-over-year
- ➤Revenue $10.499M, versus $13.752M in the prior-year quarter
Expert Statements
David Phipps, Chief Executive Officer and President of NextPlat Corp
“Our third quarter results reflect continued year-over-year improvement across the business, driven by the refocusing of our healthcare operations on high-value, high-margin services designed to deliver consistent bottom-line results in what remains a dynamic market.”
David Phipps, Chief Executive Officer and President of NextPlat Corp
“Our focus remains on growth and profitability through our differentiated, high-value healthcare services and expanding community pharmacy network, including our new Scott's location near Pensacola and a new pharmacy in Jacksonville, supported by a more efficient operating structure.”
David Phipps, Chief Executive Officer and President of NextPlat Corp
“Looking ahead, we anticipate further progress on our growth initiatives, including selective acquisitions, the introduction of new value-added services such as automated dispensing, and entry into new online healthcare and consumer markets”
NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approximately 66% Reduction in Net Loss PR Newswire
Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pharmacy Footprint
Get started
Create a free account to read the full story.